Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label …

…, R Gervais, C Locher, B Milleron, Q Tran, MP Lebitasy… - The Lancet, 2016 - thelancet.com
Background Malignant pleural mesothelioma is an aggressive cancer with poor prognosis,
linked to occupational asbestos exposure. Vascular endothelial growth factor is a key …

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 …

…, J Bennouna, J Tredaniel, A Ducoloné, MP Lebitasy… - The Lancet, 2011 - thelancet.com
Background Platinum-based doublet chemotherapy is recommended to treat advanced non-small-cell
lung cancer (NSCLC) in fit, non-elderly adults, but monotherapy is recommended …

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib

…, E Longchampt, S Isaac-Sibille, MP Lebitasy… - Lung cancer, 2010 - Elsevier
There is no optimal established therapy for treating advanced or recurrent adenocarcinoma
with bronchioloalveolar carcinoma features (ADC-BAC), and it remains unclear whether …

[HTML][HTML] Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997

J Foeglé, G Hédelin, MP Lebitasy, A Purohit… - Journal of Thoracic …, 2007 - Elsevier
Introduction The literature suggests that lung cancer may represent a different disease in
women compared with men and that gender specificities have been reported mostly in clinical …

Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program

…, A Jaffré, A Goncalves, MP Lebitasy… - Therapeutic …, 2021 - journals.sagepub.com
Background: Bone-only (BO) metastatic breast cancer (MBC) is considered a more favorable
entity than other MBC presentations. However, only few retrospective series and data from …

Management and outcome of French elderly patients with lung cancer: an IFCT survey

…, D Braun, P Girard, JL Breton, MP Lebitasy… - Revue des maladies …, 2010 - europepmc.org
Background Lung cancer in the elderly is considerably increasing in frequency, representing
a public health issue. Those patients are underrepresented in clinical trials and probably …

Women and small cell lung cancer: social characteristics, medical history, management and survival: a retrospective study of all the male and female cases diagnosed …

B Mennecier, MP Lebitasy, L Moreau, G Hedelin… - Lung cancer, 2003 - Elsevier
The literature make it clear that lung cancer in women differs from that in men in several
specific aspects. We conducted a retrospective study of the 967 consecutive recorded patients (…

[HTML][HTML] Non-small-cell lung cancer in a French department,(1982–1997): management and outcome

J Foegle, G Hedelin, MP Lebitasy, A Purohit… - British journal of …, 2005 - nature.com
Addition of chemotherapy to the treatment of non-small-cell lung cancer (NSCLC) resulted
in a modest but clear improvement in the survival of selected patients. To ascertain if this …

[HTML][HTML] Long-term stability of 5-Fluorouracil in 0.9% sodium chloride after freezing, microwave thawing, and refrigeration

L Galanti, MP Lebitasy, JD Hecq… - … Canadian Journal of …, 2009 - ncbi.nlm.nih.gov
… Massin P Lebitasy Massin P Lebitasy is a pharmacist with the Medical Laboratory, UCL
Mont… Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. Effect of freezing, long-…

Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994

MP Lebitasy, G Hedelin, A Purohit, L Moreau… - British journal of …, 2001 - nature.com
Recent analyses of series of small-cell lung cancer (SCLC) patients included in clinical trials
have shown improved survival over time, but it has been impossible to determine whether …